PEB $1.120 -$0.010 / -0.88% 52 Week Change: $0.559 / 99.59%
Issued By
Pacific Edge Limited
ISIN
NZPEBE0002S1
Security Type
Ordinary Shares
Indices
NZX 50, NZX 50 Portfolio, NZX SciTech, NZX MidCap, and NZX All
Sector
Services / Finance & Other Services

Activity

Trading Status Trading
Trades 55
Value $364,053.64
Volume 325,953
Capitalisation (000s) $356,850

Performance

Open $1.130
High $1.150
Low $1.100
High Bid $1.120
Low Offer $1.130

Fundamental

P/E 0.000
EPS -$0.029
NTA $0.024
Gross Div Yield 0.000%
Shares Issued 318,615,921
Data up to date as of 23/04/2014 07:18PM

Company Description

Biotechnology company, specialising diagnosis and characterisation of diseases.

Price History (30 days)

PEB 30 day price history

Upcoming Dividends

There are no upcoming dividends in this security at this time.

Recent Announcements

View more announcements
Title Date Type
Conversion of Pacific Edge Limited Preference S... 14 Mar 2014, 10:42am ALLOT
Ongoing Disclosure Notice - Anatole Masfen 12 Mar 2014, 2:43pm RELINT
NZXR Price Enquiry into Pacific Edge Limited ("... 11 Mar 2014, 4:02pm S/PRICE
Ongoing Disclosure Notice - D Darling 10 Mar 2014, 4:46pm RELINT
Ongoing Disclosure Notice - Christopher Swann 7 Mar 2014, 12:14pm RELINT
P Denotes Price Sensitive announcements

Company Analysis

Pacific Edge Limited (PEB) was formed in August 2001 following acquisition of intellectual property from the University of Otago. The company is involved in the development of tools for early detection, diagnosis and characterisation of diseases, particularly cancer. It plans to develop sophisticated diagnostic and screening tools based ...(more)